Earningsreport

Q1/2019 6/30/2019 EPS 35.580 ZacksConsensus N/A ActVsEst N/A - N/A

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors